Skip to main content

Table 1 Characteristics of 117 included studies and demographics of included patients

From: Physical rehabilitation interventions in the intensive care unit: a scoping review of 117 studies

Study characteristics

Countries, n (%)

 USA

41 (35)

 Australia

17 (15)

 Brazil

9 (8)

 Belgium

8 (7)

 Italy

6 (5)

 UK

5 (4)

 Taiwan

4 (3)

 Greece

3 (3)

 Othersa

24 (21)

Number of centers, n studies (%)

 Single-center

107 (91)

 Multi-center

10 (9)

 Median number of centers (first, third quartiles)

5 (5, 14)

ICU type, n (%)

 Medical/surgical

22 (19)

 Mixed (medical, surgical, cardiovascular, neurological)

22 (19)

 Medical

20 (17)

 Neurological

15 (13)

 Respiratory

9 (8)

 Surgical

9 (8)

 Cardiovascular

3 (3)

 Not reported

17 (15)

Reported Severity of Illness Scale, n studies (%)

 APACHE II

58 (50)

 APACHE III

7 (6)

 SAPS II

3 (3)

 SOFA

3 (3)

 Othersc

7 (6)

 Not reported

38 (32)

Study design, n (%)

 Randomized clinical trialb

39 (33)

 Case series

30 (26)

 Cohort

25 (21)

 Before-after

14 (12)

 Two-group comparison

9 (8)

Sample size (enrolled), median (first, third quartiles)

 Randomized clinical trialb

46 (25, 87)

 Case series

23 (15, 60)

 Cohort

101 (43, 246)

 Before-after

141 (80, 582)

 Two-group comparison

59 (24, 193)

 Overall

57 (25, 112)

Intervention type, n (% of all types)

 Progressive mobility

38 (32)

 Multicomponent

35 (30)

 Passive or active exercise alone

18 (15)

 Neuromuscular electrical stimulation

17 (15)

 Cycling

8 (7)

 Unable to classify

1 (1)

Patient demographics

Age (years) median (first, third quartiles)

59.4 (55.0, 63.9)

Sex (male, n patients (%))

9078 (51)

Admission Diagnosis, n patients (% of total)

 Respiratory

2737 (15)

 Neurological

2074 (12)

 Post-surgical

1891 (11)

 Medical

1464 (8)

 Cardiovascular

1094 (6)

 Sepsis/infection

1024 (6)

 Unspecified

4218 (24)

 Othersd

504 (3)

 Not reported, n studies

15

  1. APACHE II Acute Physiology and Chronic Health Evaluation II, a 13-item instrument with scores from 0 to 71, higher scores representing more severe illness; APACHE III Acute Physiology and Chronic Health Evaluation III, a prognostic scale with scores from 0 to 299, higher scores indicating a poorer prognosis; SAPS II Simplified Acute Physiology Score II, a 17-item scale with scores from 0 to 163, higher scores representing increased risk of hospital mortality; SOFA Sequential Organ Failure Assessment, a 6-item scale to predict mortality with scores from 6 to 24, higher scores indicate poorer prognosis
  2. aOther includes China (n = 2), Austria (n = 2), Turkey (n = 2), Germany (n = 1), France (n = 2), Sweden (n = 2), 1 study each from Israel, South Korea, Egypt, South Africa, Japan, Kuwait, Argentina, Denmark, Canada, Zimbabwe, Spain, India, Switzerland
  3. bRandomized controlled trial includes randomized cross-over designs (n = 3) and within-patient randomized designs (n = 4)
  4. cOther included Glasgow Coma Scale (n = 3), Simplified Acute Physiology Score III (n = 2), Brunnstrom (n = 1), Injury Severity Score (n = 1), Braden Scale (n = 1)
  5. dOther includes trauma (n = 397, 2.2%), oncology (n = 41, 0.2%), transplants (n = 43, 0.2%), extracorporeal membrane oxygenation or left ventricular assist device support (n = 9, 0.1%), musculoskeletal (n = 11, 0.1%), burns (n = 3, 0.02%)